Carrara G.; Argnani L.; Zanetti A.; Zabotti A.; Silvagni E.; Sebastiani G.D.; Sebastiani M.; Scire C.A., Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology, «SCANDINAVIAN JOURNAL OF RHEUMATOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]
Broccoli, Alessandro; Argnani, Lisa; Coppola, Paolo Elia; Gentilini, Marianna; Bagnato, Gianmarco; Lolli, Ginevra; Carella, Matteo; Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Zinzani, Pier Luigi, Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series, «TUMORI», 2022, Online ahead of print, pp. 3008916221090327 - 3008916221090327 [articolo]
Argnani L, Broccoli A, Pellegrini C, Fabbri A, Puccini B, Bruna R, Tisi MC, Masia F, Flenghi L, Nizzoli ME, Musso M, Salerno M, Scalzulli PR, Dessi' D, Ferrarini I, Pennese E, Lucchini E, Rossi FG, Minoia C, Gherlinzoni F, Musto P, Patti C, Stefoni V, Zinzani PL., Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy., «HEMASPHERE», 2022, 6, pp. 1 - 5 [articolo]Open Access
Casadei, B.; Argnani, L.; Broccoli, A.; Patti, C.; Stefani, P. M.; Cuneo, A.; Casaluci, G. M.; Visco, C.; Gini, G.; Pane, F.; D'Alo, F.; Luzi, D.; Cantonetti, M.; Pozzi, S.; Musuraca, G.; Rosignoli, C.; Arcari, A.; Kovalchuk, S.; Tani, M.; Tisi, M. C.; Petrini, M.; Stefoni, V.; Zinzani, P. L., Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study, «CANCERS», 2022, 14, Article number: 654, pp. 1 - 11 [articolo]Open Access
Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L., A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. e817 - e819 [articolo]
Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L., Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report, «ACTA HAEMATOLOGICA», 2021, 13, pp. 1-3 - 3 [articolo]
Lolli, G.; Casadei, B.; Pellegrini, C.; Argnani, L.; Cocito, F.; Zinzani, P. L., Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report, «TUMORI», 2021, 107, pp. NP105 - NP107 [articolo]
Perrone, Anna Myriam; Ravegnini, Gloria; Miglietta, Stefano; Argnani, Lisa; Ferioli, Martina; De Crescenzo, Eugenia; Tesei, Marco; Di Stanislao, Marco; Girolimetti, Giulia; Gasparre, Giuseppe; Porcelli, Anna Maria; De Terlizzi, Francesca; Zamagni, Claudio; Morganti, Alessio Giuseppe; De Iaco, Pierandrea, Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies, «CANCERS», 2021, 13, Article number: 1993, pp. 1 - 17 [articolo]Open Access
Casadei, B; Guadagnuolo, S; Barone, M; Turroni, S; Argnani, L; Brigidi, P; Zinzani, PL, Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study, in: Blood 138, 2021, 138, pp. 2957 - 2957 (atti di: 63rd ASH Annual Meeting, Atlanta, 11-14/12/2021) [Contributo in Atti di convegno]
Morigi A.; Stefoni V.; Argnani L.; Broccoli A.; Zinzani P.L., Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. e678 - e679 [articolo]
Broccoli, A.; Argnani, L.; Zinzani, P. L., Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?, «CURRENT HEMATOLOGIC MALIGNANCY REPORTS», 2021, 16, pp. 82 - 88 [articolo]
Broccoli A.; Argnani L.; Morigi A.; Nanni L.; Casadei B.; Pellegrini C.; Stefoni V.; Zinzani P.L., Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 5845, pp. 5845 - 5845 [articolo]Open Access
Tarantelli, C.; Argnani, L.; Zinzani, P. L.; Bertoni, F., Pi3kδ inhibitors as immunomodulatory agents for the treatment of lymphoma patients, «CANCERS», 2021, 13, pp. 5535 - 5535 [articolo]Open Access
Perrone A.M.; Ferioli M.; Argnani L.; De Terlizzi F.; Pirovano C.; Covarelli P.; Dondi G.; Tesei M.; De Crescenzo E.; Ravegnini G.; Galuppi A.; Morganti A.G.; De Iaco P., Quality of life with vulvar carcinoma treated with palliative electrochemotherapy: The elechtra (electrochemotherapy vulvar cancer) study, «CANCERS», 2021, 13, Article number: 1622, pp. 1622 - 1632 [articolo]Open Access
Coppola P.E.; Broccoli A.; Argnani L.; Casadei B.; Stefoni V.; Bertuzzi C.; Sabattini E.; Zinzani P.L., Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 3540 - 3543 [articolo]
